Vickro Biopharma Private Limited, a active private limited company, was established on 25 November 2016 in Hyderabad, Telangana, India. Engaging in application development & software solutions within the manufacturing sector, it holds CIN: U24304TG2016PTC113121. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 25 professional, Its leadership includes Indirapriyadarsini Kankanampati (Director), Kishore Babu Turlapati (Director). It holds ₹20.78 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 7, Survey No 451 H.No. 5-5-35/276/1 Shakthipeetham I.E. Kukatpally, Hyderabad, Telangana, 500072.
U24304TG2016PTC113121
113121
25 November 2016
₹1.00 Cr
₹1.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Vickro Biopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Indirapriyadarsini Kankanampati | Director | 25 Nov 2016 | Current |
| Kishore Babu Turlapati | Director | 25 Nov 2016 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vickro Biopharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 70.84% increase. The company also saw a substantial improvement in profitability, with a 31.46% increase in profit. The company's net worth Soared by an impressive increase of 51.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Vickro Biopharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹207,750,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2025 | Axis Bank Limited | ₹15.00 Cr | Open |
| 31 Mar 2025 | Axis Bank Limited | ₹4.00 Cr | Open |
| 31 Dec 2024 | Axis Bank Limited | ₹0.81 M | Open |
| 16 Aug 2024 | Axis Bank Limited | ₹1.30 Cr | Open |
| 21 Apr 2022 | Axis Bank Limited | ₹3.94 M | Open |
Explore comprehensive loan charge details -
Vickro Biopharma has a workforce of 25 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Vickro Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vickro Biopharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Axis Bank Limited amounted to Rs. 15.00 Cr with Charge ID 101095557 was registered on 31 Mar 2025. was completed.
A charge with Axis Bank Limited amounted to Rs. 4.00 Cr with Charge ID 101095556 was registered on 31 Mar 2025. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 0.08 Cr with Charge ID 101038157 was registered on 31 Dec 2024. was completed.
Vickro Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
A charge with Axis Bank Limited amounted to Rs. 1.30 Cr with Charge ID 100963565 was registered on 16 Aug 2024. was recorded as a recent event.
Vickro Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The CIN of Vickro Biopharma Private Limited is U24304TG2016PTC113121.
Vickro Biopharma Private Limited is headquartered at Plot No 7, Survey No 451 H.No. 5-5-35/276/1 Shakthipeetham I.E. Kukatpally, Hyderabad, Telangana, 500072.
Vickro Biopharma Private Limited was incorporated on 25 November 2016.
The current directors of Vickro Biopharma Private Limited are
The primary industry of Vickro Biopharma Private Limited is Manufacturing.
Vickro Biopharma Private Limited is unlisted.
The authorized capital of Vickro Biopharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Vickro Biopharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX